Gapping down
In reaction to earnings/guidance:
- F -4.8% (reaffirms FY22 EBIT but inflation-related supplier costs to run $1 bln higher than expected)
Other news:
- NVTA -4.2% (reports real-world ciitizen data utilized in Praxis Precision Medicines' PRAX-222 IND Filing)
- COIN -0.8% (announces new fee structures)
Analyst comments:
- WY -2.3% (downgraded to Neutral from Buy at BofA Securities)
- WDC -1.5% (downgraded to Hold from Buy at Deutsche Bank)